Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2023 06:50 ET | Source: McEwen Mining

McEwen Copper Closes ARS $30 Billion Investment by Stellantis

TORONTO, Feb. 27, 2023 (GLOBE NEWSWIRE) -- McEwen Copper Inc., a subsidiary of McEwen Mining Inc. (NYSE: MUX) (TSX: MUX), is pleased to announce closing of an ARS $30 billion investment by...
February 23, 2023 16:01 ET | Source: Standard Lithium

Standard Lithium to Participate in the BMO 32nd Global Metals, Mining & Critical Minerals Conference

VANCOUVER, British Columbia, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE: SLI) (FRA: S5L), a leading near-commercial lithium...
February 18, 2022 11:44 ET | Source: Reunion Gold Corporation

Reunion Gold Announces Update of Technical Information on Its Website and BMO Conference Core Shack Presentation

LONGUEUIL, Quebec, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Reunion Gold Corporation (TSXV: RGD) (the "Company"), is pleased to announce that it has updated the Oko West project description on its website,...
December 01, 2020 10:53 ET | Source: Ingredion Incorporated

Ingredion to Present at BMO 2020 Growth & ESG Conference

WESTCHESTER, Ill., Dec. 01, 2020 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food and beverage manufacturing industry, today...
June 18, 2020 08:00 ET | Source: Morphic Therapeutic

Morphic to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference

WALTHAM, Mass., June 18, 2020 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF), a biopharmaceutical company developing a new generation of oral therapies targeting integrins for the treatment...
June 17, 2020 16:05 ET | Source: Trevi Therapeutics

Trevi Therapeutics to Present at BMO Prescriptions for Success Healthcare Virtual Conference

NEW HAVEN, Conn., June 17, 2020 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine...
May 06, 2020 16:30 ET | Source: Ingredion Incorporated

Ingredion to Present at BMO Capital Markets 15th Annual Farm to Market Conference

WESTCHESTER, Ill., May 06, 2020 (GLOBE NEWSWIRE) -- Ingredion Incorporated (NYSE: INGR), a leading global provider of ingredient solutions to the food manufacturing industry, announced today that it...
November 28, 2018 16:30 ET | Source: Retrophin, Inc.

Retrophin to Present at the BMO Prescriptions for Success Healthcare Conference

SAN DIEGO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX) today announced that Stephen Aselage, chief executive officer, will present at the BMO 2018 Prescriptions for Success...
December 12, 2017 08:00 ET | Source: VBI Vaccines, Inc.

VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI) today announced that Jeff Baxter, President and CEO, will present at the BMO Capital Markets...